1. Aaby, P., Stabell Benn, C., Flanagan, K.L., Klein SL, Kollmann TB, Lynn DL, et al. (2020). The non-specific and sex-differential effects of vaccines. Nature Rev Immunol. Available at: https://www.nature.com/articles/s41577-020-0338-x.pdf. Accessed 30 Sept 2020.
2. Arts, R. J. W., Moorlag, S. J. C. F. M., Novakovic, B., Wang, S. Y., Oosting, M., Kumar, V., et al. (2018). BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host & Microbe, 23, 89–100.e5.
3. Canadian Institute for Health Information. (2020). Health workforce 2018. Available at : https://www.cihi.ca/en/health-workforce. Accessed 30 Sept 2020.
4. Cernuschi, T., Malvolti, S., Nickels, E., Friede, M., et al. (2018). Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance. Vaccine, 36, 498–506.
5. CIQ - Comité sur l’immunisation du Québec. (2016). Avis sur la pertinence de la réintroduction du vaccin bacille Calmette-Guérin (BCG) au Nunavik dans le contexte d’une recrudescence de la tuberculose. Québec, Institut national de santé publique. Available at : https://www.inspq.qc.ca/sites/default/files/publications/2179_pertinence_reintroduction_vaccin_tuberculose_nunavik.pdf. Accessed 30 Sept 2020.